Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 713

1.

Prevalence, Magnitude, and Genotype Distribution of Urinary Cytomegalovirus (CMV) Shedding Among CMV-Seropositive Children and Adolescents in the United States.

White JL, Patel EU, Abraham AG, Grabowski MK, Arav-Boger R, Avery RK, Quinn TC, Tobian AAR.

Open Forum Infect Dis. 2019 Jun 5;6(7):ofz272. doi: 10.1093/ofid/ofz272. eCollection 2019 Jul.

2.

Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai, Uganda.

Rubin LH, Saylor D, Nakigozi G, Nakasujja N, Robertson K, Kisakye A, Batte J, Mayanja R, Anok A, Lofgren SM, Boulware DR, Dastgheyb R, Reynolds SJ, Quinn TC, Gray RH, Wawer MJ, Sacktor N.

J Neurovirol. 2019 Jun 19. doi: 10.1007/s13365-019-00768-5. [Epub ahead of print]

PMID:
31218522
3.

Immune Correlates of Disease Progression in Linked HIV-1 Infection.

Tuen M, Bimela JS, Banin AN, Ding S, Harkins GW, Weiss S, Itri V, Durham AR, Porcella SF, Soni S, Mayr L, Meli J, Torimiro JN, Tongo M, Wang X, Kong XP, Nádas A, Kaufmann DE, Brumme ZL, Nanfack AJ, Quinn TC, Zolla-Pazner S, Redd AD, Finzi A, Gorny MK, Nyambi PN, Duerr R.

Front Immunol. 2019 May 14;10:1062. doi: 10.3389/fimmu.2019.01062. eCollection 2019.

4.

Reply to MacDonald et al.

Patel EU, Mehta SH, Boon D, Quinn TC, Thomas DL, Tobian AAR.

Clin Infect Dis. 2019 May 24. pii: ciz441. doi: 10.1093/cid/ciz441. [Epub ahead of print] No abstract available.

PMID:
31125394
5.

Inferring HIV-1 transmission networks and sources of epidemic spread in Africa with deep-sequence phylogenetic analysis.

Ratmann O, Grabowski MK, Hall M, Golubchik T, Wymant C, Abeler-Dörner L, Bonsall D, Hoppe A, Brown AL, de Oliveira T, Gall A, Kellam P, Pillay D, Kagaayi J, Kigozi G, Quinn TC, Wawer MJ, Laeyendecker O, Serwadda D, Gray RH, Fraser C; PANGEA Consortium and Rakai Health Sciences Program.

Nat Commun. 2019 Mar 29;10(1):1411. doi: 10.1038/s41467-019-09139-4.

6.

Field performance of the INSTI HIV-1/-2 antibody test in two South African antenatal clinics.

Mayaphi SH, Martin DJ, Quinn TC, Stoltz AC.

J Med Virol. 2019 Jul;91(7):1355-1359. doi: 10.1002/jmv.25447. Epub 2019 Mar 18.

PMID:
30840772
7.

Phylogenetic methods inconsistently predict direction of HIV transmission among heterosexual pairs in the HPTN052 cohort.

Rose R, Hall M, Redd AD, Lamers S, Barbier AE, Porcella SF, Hudelson SE, Piwowar-Manning E, McCauley M, Gamble T, Wilson EA, Kumwenda J, Hosseinipour MC, Hakim JG, Kumarasamy N, Chariyalertsak S, Pilotto JH, Grinsztejn B, Mills LA, Makhema J, Santos BR, Chen YQ, Quinn TC, Fraser C, Cohen MS, Eshleman SH, Laeyendecker O.

J Infect Dis. 2018 Dec 24. doi: 10.1093/infdis/jiy734. [Epub ahead of print]

PMID:
30590741
8.

Validation of the Limiting Antigen Avidity Assay to Estimate Level and Trends in HIV Incidence in an A/D Epidemic in Rakai, Uganda.

Laeyendecker O, Gray RH, Grabowski MK, Reynolds SJ, Ndyanabo A, Ssekasanvu J, Fernandez RE, Wawer MJ, Serwadda D, Quinn TC.

AIDS Res Hum Retroviruses. 2019 Apr;35(4):364-367. doi: 10.1089/AID.2018.0207. Epub 2019 Jan 29.

PMID:
30560723
9.

Short Communication: The Interaction of HIV Set Point Viral Load and Subtype on Disease Progression.

McPhee E, Grabowski MK, Gray RH, Ndyanabo A, Ssekasanvu J, Kigozi G, Makumbi F, Serwadda D, Quinn TC, Laeyendecker O.

AIDS Res Hum Retroviruses. 2019 Jan;35(1):49-51. doi: 10.1089/AID.2018.0165.

PMID:
30520309
10.

Results of Early Virologic Monitoring May Facilitate Differentiated Care Monitoring Strategies for Clients on ART, Rakai, Uganda.

Ssempijja V, Chang LW, Nakigozi G, Ndyanabo A, Quinn TC, Cobelens F, Wawer M, Gray R, Serwadda D, Reynolds SJ.

Open Forum Infect Dis. 2018 Oct 9;5(10):ofy212. doi: 10.1093/ofid/ofy212. eCollection 2018 Oct.

11.

Limited anti-HIV neutralizing antibody breadth and potency before and after HIV superinfection in Danish men who have sex with men.

Redd AD, Helleberg M, Sievers M, Schmidt SD, Doria-Rose NA, Bruno D, Traeger S, Martens C, Fonager J, Kronborg G, Packman Z, Mascola JR, Porcella SF, Gerstoft J, Quinn TC.

Infect Dis (Lond). 2019 Jan;51(1):56-61. doi: 10.1080/23744235.2018.1500708. Epub 2018 Oct 14.

PMID:
30317905
12.

Universal Target Capture of HIV Sequences From NGS Libraries.

Yamaguchi J, Olivo A, Laeyendecker O, Forberg K, Ndembi N, Mbanya D, Kaptue L, Quinn TC, Cloherty GA, Rodgers MA, Berg MG.

Front Microbiol. 2018 Sep 13;9:2150. doi: 10.3389/fmicb.2018.02150. eCollection 2018.

13.

Limited Coverage of Hepatitis C Virus Testing in the United States, 2013-2017.

Patel EU, Mehta SH, Boon D, Quinn TC, Thomas DL, Tobian AAR.

Clin Infect Dis. 2019 Apr 8;68(8):1402-1405. doi: 10.1093/cid/ciy803.

PMID:
30239645
14.

A Window Into the HIV Epidemic from a South African Emergency Department.

Hansoti B, Stead D, Eisenberg A, Mvandaba N, Mwinnyaa G, Patel EU, Parrish A, Reynolds SJ, Redd AD, Fernandez R, Rothman RE, Laeyendecker O, Quinn TC.

AIDS Res Hum Retroviruses. 2019 Feb;35(2):139-144. doi: 10.1089/AID.2018.0127. Epub 2018 Nov 13.

PMID:
30215268
15.

Short Communication: Dried Blood Spots Stored at Room Temperature Should Not Be Used for HIV Incidence Testing.

Eisenberg AL, Patel EU, Packman ZR, Fernandez RE, Piwowar-Manning E, Hamilton EL, MacPhail C, Hughes J, Pettifor A, Kallas EG, Busch MP, Murphy G, Quinn TC, Eshleman SH, Laeyendecker O; for HPTN 068 and CEPHIA.

AIDS Res Hum Retroviruses. 2018 Dec;34(12):1013-1016. doi: 10.1089/AID.2018.0138. Epub 2018 Oct 17.

PMID:
30215267
16.

Implementing emergency department-based HIV testing in a low-resource setting: The value of a structured feasibility assessment tool.

Whalen M, Mda P, Parrish A, Quinn TC, Rothman R, Stead D, Hansoti B.

South Afr J HIV Med. 2018 Jul 16;19(1):793. doi: 10.4102/sajhivmed.v19i1.793. eCollection 2018.

17.

Evolution of HIV-1 within untreated individuals and at the population scale in Uganda.

Raghwani J, Redd AD, Longosz AF, Wu CH, Serwadda D, Martens C, Kagaayi J, Sewankambo N, Porcella SF, Grabowski MK, Quinn TC, Eller MA, Eller LA, Wabwire-Mangen F, Robb ML, Fraser C, Lythgoe KA.

PLoS Pathog. 2018 Jul 27;14(7):e1007167. doi: 10.1371/journal.ppat.1007167. eCollection 2018 Jul.

18.

Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission.

Bekker LG, Alleyne G, Baral S, Cepeda J, Daskalakis D, Dowdy D, Dybul M, Eholie S, Esom K, Garnett G, Grimsrud A, Hakim J, Havlir D, Isbell MT, Johnson L, Kamarulzaman A, Kasaie P, Kazatchkine M, Kilonzo N, Klag M, Klein M, Lewin SR, Luo C, Makofane K, Martin NK, Mayer K, Millett G, Ntusi N, Pace L, Pike C, Piot P, Pozniak A, Quinn TC, Rockstroh J, Ratevosian J, Ryan O, Sippel S, Spire B, Soucat A, Starrs A, Strathdee SA, Thomson N, Vella S, Schechter M, Vickerman P, Weir B, Beyrer C.

Lancet. 2018 Jul 28;392(10144):312-358. doi: 10.1016/S0140-6736(18)31070-5. Epub 2018 Jul 20. Review. No abstract available.

19.

Quantitation of the latent HIV-1 reservoir from the sequence diversity in viral outgrowth assays.

Poon AFY, Prodger JL, Lynch BA, Lai J, Reynolds SJ, Kasule J, Capoferri AA, Lamers SL, Rodriguez CW, Bruno D, Porcella SF, Martens C, Quinn TC, Redd AD.

Retrovirology. 2018 Jul 5;15(1):47. doi: 10.1186/s12977-018-0426-1.

20.

Molecular screening for Neisseria gonorrhoeae antimicrobial resistance markers in Nigerian men who have sex with men and transgender women.

Hardick J, Crowell TA, Lombardi K, Akintunde A, Odeyemi S, Ivo A, Eluwa G, Njab J, Baral SD, Nowak RG, Quinn TC, Barbian K, Anzick S, Adebajo S, Charurat ME, Ake J, Gaydos CA.

Int J STD AIDS. 2018 Nov;29(13):1273-1281. doi: 10.1177/0956462418780050. Epub 2018 Jul 4.

21.

Shifting the HIV Paradigm from Care to Cure: Proceedings from the Caribbean Expert Summit in Barbados, August 2017.

Landis RC, Abayomi EA, Bain BC, Greene E, Janossy G, Joseph P, Kerrigan D, McCoy JP, Nunez C, O'Gorman M, Pastoors A, Parekh BS, Quimby KR, Quinn TC, Robertson KR, Thomas R, van Gorp E, Vermund SH, Wilson V.

AIDS Res Hum Retroviruses. 2018 Jul;34(7):561-569. doi: 10.1089/AID.2017.0310. Epub 2018 Jun 5.

22.

Urogenital Chlamydia trachomatis multilocus sequence types and genovar distribution in chlamydia infected patients in a multi-ethnic region of Saratov, Russia.

Feodorova VA, Konnova SS, Saltykov YV, Zaitsev SS, Subbotina IA, Polyanina TI, Ulyanov SS, Lamers SL, Gaydos CA, Quinn TC, Motin VL.

PLoS One. 2018 Apr 11;13(4):e0195386. doi: 10.1371/journal.pone.0195386. eCollection 2018.

23.

Characterization of the Neutralizing Antibody Response in a Case of Genetically Linked HIV Superinfection.

Ssemwanga D, Doria-Rose NA, Redd AD, Shiakolas AR, Longosz AF, Nsubuga RN, Mayanja BN, Asiki G, Seeley J, Kamali A, Ransier A, Darko S, Walker MP, Bruno D, Martens C, Douek D, Porcella SF, Quinn TC, Mascola JR, Kaleebu P.

J Infect Dis. 2018 Apr 23;217(10):1530-1534. doi: 10.1093/infdis/jiy071.

24.

Patient and provider attitudes to emergency department-based HIV counselling and testing in South Africa.

Hansoti B, Hill SE, Whalen M, Stead D, Parrish A, Rothman R, Hsieh YH, Quinn TC.

South Afr J HIV Med. 2017 May 31;18(1):707. doi: 10.4102/sajhivmed.v18i1.707. eCollection 2017.

25.

Prevalence and Correlates of Trichomonas vaginalis Infection Among Men and Women in the United States.

Patel EU, Gaydos CA, Packman ZR, Quinn TC, Tobian AAR.

Clin Infect Dis. 2018 Jul 2;67(2):211-217. doi: 10.1093/cid/ciy079.

26.

HIV testing in a South African Emergency Department: A missed opportunity.

Hansoti B, Stead D, Parrish A, Reynolds SJ, Redd AD, Whalen MM, Mvandaba N, Quinn TC.

PLoS One. 2018 Mar 13;13(3):e0193858. doi: 10.1371/journal.pone.0193858. eCollection 2018.

27.

Longitudinal change in the serology of antibodies to Chlamydia trachomatis pgp3 in children residing in a trachoma area.

West SK, Munoz B, Kaur H, Dize L, Mkocha H, Gaydos CA, Quinn TC.

Sci Rep. 2018 Feb 23;8(1):3520. doi: 10.1038/s41598-018-21127-0.

28.

High risk exposure to HIV among sexually active individuals who tested negative on rapid HIV Tests in the Tshwane District of South Africa-The importance of behavioural prevention measures.

Mayaphi SH, Martin DJ, Olorunju SAS, Williams BG, Quinn TC, Stoltz AC.

PLoS One. 2018 Feb 2;13(2):e0192357. doi: 10.1371/journal.pone.0192357. eCollection 2018.

29.

HIV-1 superinfection can occur in the presence of broadly neutralizing antibodies.

Serwanga J, Ssemwanga D, Muganga M, Nakiboneka R, Nakubulwa S, Kiwuwa-Muyingo S, Morris L, Redd AD, Quinn TC, Kaleebu P; HIV Superinfection Study Group.

Vaccine. 2018 Jan 25;36(4):578-586. doi: 10.1016/j.vaccine.2017.11.075. Epub 2017 Dec 20.

PMID:
29274699
30.

The validity of self-reported antiretroviral use in persons living with HIV: a population-based study.

Grabowski MK, Reynolds SJ, Kagaayi J, Gray RH, Clarke W, Chang LW, Nakigozi G, Laeyndecker O, Redd AD, Billioux V, Ssekubugu R, Nalugoda F, Wawer MJ, Serwadda D, Quinn TC, Tobian AAR.

AIDS. 2018 Jan 28;32(3):363-369. doi: 10.1097/QAD.0000000000001706.

31.

Hepatitis E Virus Seroprevalence and Correlates of Anti-HEV IgG Antibodies in the Rakai District, Uganda.

Boon D, Redd AD, Laeyendecker O, Engle RE, Nguyen H, Ocama P, Boaz I, Ndyanabo A, Kiggundu V, Reynolds SJ, Gray RH, Wawer MJ, Purcell RH, Kirk GD, Quinn TC, Stabinski L; Rakai Health Sciences Program.

J Infect Dis. 2018 Feb 14;217(5):785-789. doi: 10.1093/infdis/jix610.

32.

Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.

Solomon SS, McFall AM, Lucas GM, Srikrishnan AK, Kumar MS, Anand S, Quinn TC, Celentano DD, Mehta SH.

PLoS Med. 2017 Nov 28;14(11):e1002460. doi: 10.1371/journal.pmed.1002460. eCollection 2017 Nov.

33.

HIV Prevention Efforts and Incidence of HIV in Uganda.

Grabowski MK, Serwadda DM, Gray RH, Nakigozi G, Kigozi G, Kagaayi J, Ssekubugu R, Nalugoda F, Lessler J, Lutalo T, Galiwango RM, Makumbi F, Kong X, Kabatesi D, Alamo ST, Wiersma S, Sewankambo NK, Tobian AAR, Laeyendecker O, Quinn TC, Reynolds SJ, Wawer MJ, Chang LW; Rakai Health Sciences Program.

N Engl J Med. 2017 Nov 30;377(22):2154-2166. doi: 10.1056/NEJMoa1702150.

34.

HIV viral load monitoring among key populations in low- and middle-income countries: challenges and opportunities.

Schwartz SR, Kavanagh MM, Sugarman J, Solomon SS, Njindam IM, Rebe K, Quinn TC, Toure-Kane C, Beyrer C, Baral S.

J Int AIDS Soc. 2017 Nov;20 Suppl 7. doi: 10.1002/jia2.25003.

35.

A systematic review of emergency department based HIV testing and linkage to care initiatives in low resource settings.

Hansoti B, Kelen GD, Quinn TC, Whalen MM, DesRosiers TT, Reynolds SJ, Redd A, Rothman RE.

PLoS One. 2017 Nov 2;12(11):e0187443. doi: 10.1371/journal.pone.0187443. eCollection 2017. Review.

36.

Impact of a community health worker HIV treatment and prevention intervention in an HIV hotspot fishing community in Rakai, Uganda (mLAKE): study protocol for a randomized controlled trial.

Chang LW, Mbabali I, Kong X, Hutton H, Amico KR, Kennedy CE, Nalugoda F, Serwadda D, Bollinger RC, Quinn TC, Reynolds SJ, Gray R, Wawer M, Nakigozi G.

Trials. 2017 Oct 23;18(1):494. doi: 10.1186/s13063-017-2243-6.

37.

Short Communication: False Recent Ratio of the Limiting-Antigen Avidity Assay and Viral Load Testing Algorithm Among Cameroonians with Long-Term HIV Infection.

Lynch BA, Patel EU, Courtney CR, Nanfack AJ, Bimela J, Wang X, Eid I, Quinn TC, Laeyendecker O, Nyambi PN, Duerr R, Redd AD.

AIDS Res Hum Retroviruses. 2017 Nov;33(11):1114-1116. doi: 10.1089/AID.2017.0084. Epub 2017 Aug 7.

38.

Treating village newcomers and travelers for trachoma: Results from ASANTE cluster randomized trial.

West SK, Munoz B, Mkocha H, Dize L, Gaydos CA, Swenor B, Ervin AM, Quinn TC.

PLoS One. 2017 Jun 29;12(6):e0178595. doi: 10.1371/journal.pone.0178595. eCollection 2017.

39.

Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients.

Nanfack AJ, Redd AD, Bimela JS, Ncham G, Achem E, Banin AN, Kirkpatrick AR, Porcella SF, Agyingi LA, Meli J, Colizzi V, Nádas A, Gorny MK, Nyambi PN, Quinn TC, Duerr R.

J Clin Microbiol. 2017 Sep;55(9):2785-2800. doi: 10.1128/JCM.00634-17. Epub 2017 Jun 28.

40.

Weak HIV Antibody Responses in Perinatally Infected Young Adults: Weak HIV Antibody Responses in Perinatally Infected Adults.

Kirkpatrick AR, Unsal AB, Blankson JN, Moore RD, Quinn TC, Hadigan C, Laeyendecker O.

Pediatr Infect Dis J. 2017 Nov;36(11):1064-1066. doi: 10.1097/INF.0000000000001649.

41.

HIV-1 full-genome phylogenetics of generalized epidemics in sub-Saharan Africa: impact of missing nucleotide characters in next-generation sequences.

Ratmann O, Wymant C, Colijn C, Danaviah S, Essex M, Frost SDW, Gall A, Gaiseitsiwe S, Grabowski M, Gray R, Guindon S, von Haeseler A, Kaleebu P, Kendall M, Kozlov A, Manasa J, Minh BQ, Moyo S, Novitsky V, Nsubuga R, Pillay S, Quinn TC, Serwadda D, Ssemwanga D, Stamatakis A, Trifinopoulos J, Wawer M, Leigh Brown A, de Oliveira T, Kellam P, Pillay D, Fraser C.

AIDS Res Hum Retroviruses. 2017 Nov;33(11):1083-1098. doi: 10.1089/AID.2017.0061. Epub 2017 May 25.

42.

Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, Uganda.

Prodger JL, Lai J, Reynolds SJ, Keruly JC, Moore RD, Kasule J, Kityamuweesi T, Buule P, Serwadda D, Nason M, Capoferri AA, Porcella SF, Siliciano RF, Redd AD, Siliciano JD, Quinn TC.

Clin Infect Dis. 2017 Oct 15;65(8):1308-1315. doi: 10.1093/cid/cix478.

43.

Erratum to: Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment.

Patel EU, Manucci J, Kahle EM, Lingappa JR, Morrow RA, Piwowar-Manning E, James A, Maluzi KF, Cheeba MM, Gray G, Kosloff B, Delany-Moretlwe S, Inambao M, Vwalika B, Quinn TC, Laeyendecker O.

BMC Infect Dis. 2017 May 19;17(1):355. doi: 10.1186/s12879-017-2454-1. No abstract available.

44.

Finding Youths at Risk for HIV Infection: Targeted Testing, Universal Testing, or Both?

Agwu AL, Quinn TC.

JAMA Pediatr. 2017 Jun 1;171(6):517-518. doi: 10.1001/jamapediatrics.2017.0329. No abstract available.

45.

Contrasting antibody responses to intrasubtype superinfection with CRF02_AG.

Courtney CR, Mayr L, Nanfack AJ, Banin AN, Tuen M, Pan R, Jiang X, Kong XP, Kirkpatrick AR, Bruno D, Martens CA, Sykora L, Porcella SF, Redd AD, Quinn TC, Nyambi PN, Dürr R.

PLoS One. 2017 Mar 13;12(3):e0173705. doi: 10.1371/journal.pone.0173705. eCollection 2017.

46.

Elevated cytomegalovirus IgG antibody levels are associated with HIV-1 disease progression and immune activation.

Patel EU, Gianella S, Newell K, Tobian AA, Kirkpatrick AR, Nalugoda F, Grabowski MK, Gray RH, Serwadda D, Quinn TC, Redd AD, Reynolds SJ.

AIDS. 2017 Mar 27;31(6):807-813. doi: 10.1097/QAD.0000000000001412.

47.

Trends and Determinants of Human Papillomavirus Concordance Among Human Immunodeficiency Virus-Positive and -Negative Heterosexual Couples in Rakai, Uganda.

Grabowski MK, Gravitt PE, Gray RH, Serwadda D, Redd AD, Kigozi G, Kong X, Nalugoda F, Wawer MJ, Quinn TC, Tobian AAR.

J Infect Dis. 2017 Mar 1;215(5):772-780. doi: 10.1093/infdis/jiw631.

48.

Penile Immune Activation and Risk of HIV Shedding: A Prospective Cohort Study.

Patel EU, Kirkpatrick AR, Grabowski MK, Kigozi G, Gray RH, Prodger JL, Redd AD, Nalugoda F, Serwadda D, Wawer MJ, Quinn TC, Tobian AA.

Clin Infect Dis. 2017 Mar 15;64(6):776-784. doi: 10.1093/cid/ciw847.

49.

Short Communication: The Impact of Viral Suppression and Viral Breakthrough on Limited-Antigen Avidity Assay Results in Individuals with Clade B HIV Infection.

Wendel SK, Longosz AF, Eshleman SH, Blankson JN, Moore RD, Keruly JC, Quinn TC, Laeyendecker O.

AIDS Res Hum Retroviruses. 2017 Apr;33(4):325-327. doi: 10.1089/AID.2016.0105. Epub 2017 Jan 11.

50.

Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) Trial: Design and Baseline Characteristics.

Ervin AM, Mkocha H, Munoz B, Dreger K, Dize L, Gaydos C, Quinn TC, West SK.

Ophthalmic Epidemiol. 2016 Dec;23(6):347-353. Epub 2016 Nov 7.

Supplemental Content

Loading ...
Support Center